Therapeutic Group: Respiratory Presentation Ipratop 0.25 Nebuliser Solution: Each 1 ml solution contains Ipratropium Bromide BP 0.25 mg. Description Ipratropium Bromide is a quaternary ammonium compound with anticholinergic properties. It appears to inhibit vagal reflexes by antagonising the action of acetylcholine (the transmitter agent released from the vagus nerve). Anticholinergics prevent the increase in intracellular […]